Patents by Inventor Jones Bryan

Jones Bryan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the acute treatment of atopic dermatitis and allergic skin hypersensitivity
    Patent number: 11834477
    Abstract: The present invention relates to a method for the acute treatment of a relapsing-remitting condition, the method comprising the step of administering to a subject in need thereof one or more doses of an effective amount of a peptide molecule as defined in claim 1 in response to or during a relapse, wherein the method causes remission of the condition.
    Type: Grant
    Filed: August 9, 2021
    Date of Patent: December 5, 2023
    Inventor: Jones Bryan
  • Method for the Treatment of a Relapsing-Remitting Condition
    Publication number: 20220024995
    Abstract: The present invention relates to a method for the acute treatment of a relapsing-remitting condition, the method comprising the step of administering to a subject in need thereof one or more doses of an effective amount of a peptide molecule as defined in claim 1 in response to or during a relapse, wherein the method causes remission of the condition.
    Type: Application
    Filed: October 12, 2021
    Publication date: January 27, 2022
    Inventor: Jones Bryan
  • METHOD FOR THE TREATMENT OF A RELAPSING-REMITTING CONDITION
    Publication number: 20210371475
    Abstract: The present invention relates to a method for the acute treatment of a relapsing-remitting condition, the method comprising the step of administering to a subject in need thereof one or more doses of an effective amount of a peptide molecule as defined in claim 1 in response to or during a relapse, wherein the method causes remission of the condition.
    Type: Application
    Filed: August 9, 2021
    Publication date: December 2, 2021
    Inventor: Jones Bryan
  • Osmotic delivery of therapeutic compounds by solubility enhancement
    Publication number: 20050053653
    Abstract: The present invention is directed to the oral osmotic delivery of therapeutic compounds that have limited solubility in an aqueous environment due to inherent hydrophobicity or to saturation limitations in the core of the osmotic system. The present invention is suitable for the osmotic delivery of glipizide and other hydrophobic drugs, but runs the spectrum to other therapeutic agents with higher aqueous solubilities, yet having a solubility limitation in an osmotic dosage unit due to high drug load.
    Type: Application
    Filed: September 5, 2003
    Publication date: March 10, 2005
    Inventors: Argaw Kidane, Shimul Ray, Padmanabh Bhatt, Jones Bryan